CSL Biotherapies Products
| Annual Report Contents > Business Features > CSL Biotherapies Feature > CSL Biotherapies Products | |||||||||||||||||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
Vaccines |
For prevention of: |
|---|---|
| Fluvax® ADT® Booster Q-Vax® Comvax* GARDASIL* H-B-Vax* II Menjugate* M-M-R* II PedvaxHIB* Pneumovax* 23 Vivotif Oral* Rotateq* Vaqta* Varivax* Rabipur* |
Influenza Diphtheria and Tetanus Q-Fever Haemophilus influenzae B and Hepatitis B infection Cervical cancer Hepatitis B infection Meningococcal C disease Measles, mumps and rubella Haemophilus influenzae B Pneumococcal infection Typhoid infection Rotavirus-induced gastroenteritis Hepatitis A infection Varicella Rabies infection |
Anti-infectives |
For treatment of: |
|---|---|
| BenPen® Fucidin* |
Bacterial infections Bacterial infections |
Other products |
For treatment of: |
|---|---|
| Antivenoms Cervidil* Daivobet* Daivonex* Epi-Pen* Flomaxtra* Modavigil* Tramal* |
Envenomation Complications during childbirth requiring induced labour Psoriasis Psoriasis Severe allergic reactions Benign prostatic hyperplasia Excessive daytime sleepiness in narcolepsy Moderate to severe pain |
 |
 | |||||||||||||||||||||||||||
Trademarks
|
||||||||||||||||||||||||||||
| CSL, Bioplasma and ZLB are all trademarks of the CSL Group. | |
| ® | Registered trademark of CSL Limited or its affiliates. |
| ™ | Trademark of CSL Limited or its affiliates. |
| * | Trademarks of companies other than CSL and referred to in this Annual Report are listed below: |
| Merck & Co. Inc. | Comvax H-B-Vax II M-M-R II PedvaxHIB Pneumovax Vaqta Varivax RotaTeq Gardasil |
| Merck KGaA | EpiPen |
| Berna Biotech | Vivotif Oral |
| Novartis | Menjugate Rabipur |
| Controlled Therapeutics (Scotland) Limited | Cervidil |
| Leo Pharmaceutical Products Limited AS | Daivonex Daivobet Fucidin |
| Astellas | Flomaxtra |
| Cephalon Inc | Modavigil |
| Grunenthal GmbH | Tramal |
